Medpace Holdings Research and Development Expenses 2014-2024 | MEDP
Medpace Holdings annual/quarterly research and development expenses history and growth rate from 2014 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Medpace Holdings research and development expenses for the quarter ending March 31, 2024 were $M, a NAN% increase year-over-year.
- Medpace Holdings research and development expenses for the twelve months ending March 31, 2024 were $0M, a NAN% increase year-over-year.
- Medpace Holdings annual research and development expenses for 2023 were $0B, a NAN% decline from 2022.
- Medpace Holdings annual research and development expenses for 2022 were $0B, a NAN% decline from 2021.
- Medpace Holdings annual research and development expenses for 2021 were $0B, a NAN% decline from 2020.
| Medpace Holdings Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| 2015 | $ |
| 2014 | $ |
| 2013 | $ |
| Medpace Holdings Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2014-12-31 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.186B | $1.886B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $127.298B | 15.97 |
| Cencora (COR) | United States | $44.302B | 17.27 |
| ICON (ICLR) | Ireland | $25.963B | 24.51 |
| DiDi Global (DIDIY) | China | $23.233B | 0.00 |
| Avantor (AVTR) | United States | $16.975B | 24.99 |
| CochLear (CHEOY) | Australia | $14.527B | 0.00 |
| Revvity (RVTY) | United States | $13.602B | 23.86 |
| Viatris (VTRS) | United States | $13.074B | 3.91 |
| Natera (NTRA) | United States | $13.074B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.216B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.415B | 21.85 |
| Solventum (SOLV) | United States | $10.774B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.566B | 0.00 |
| HealthEquity (HQY) | United States | $6.796B | 50.78 |
| Organon (OGN) | United States | $5.606B | 5.32 |
| Doximity (DOCS) | United States | $5.229B | 36.40 |
| Bausch + Lomb (BLCO) | Canada | $5.150B | 20.63 |
| PACS (PACS) | United States | $4.236B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.283B | 30.03 |
| Sotera Health (SHC) | United States | $3.196B | 15.68 |
| Life Times (LTH) | United States | $3.040B | 31.85 |
| GoodRx Holdings (GDRX) | United States | $2.807B | 106.86 |
| Progyny (PGNY) | United States | $2.675B | 46.05 |
| NovoCure (NVCR) | Jersey | $2.366B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.230B | 8.84 |
| Agilon Health (AGL) | United States | $2.225B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.159B | 0.00 |
| Premier (PINC) | United States | $2.061B | 8.82 |
| BrightSpring Health Services (BTSG) | United States | $1.965B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.557B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.388B | 0.00 |
| Embecta (EMBC) | United States | $0.833B | 5.67 |
| CareDx (CDNA) | United States | $0.807B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Pediatrix Medical (MD) | United States | $0.651B | 6.91 |
| Auna S.A (AUNA) | Luxembourg | $0.645B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.585B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.536B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.503B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.448B | 0.00 |
| Enhabit (EHAB) | United States | $0.414B | 41.25 |
| ModivCare (MODV) | United States | $0.391B | 7.32 |
| MultiPlan (MPLN) | United States | $0.380B | 0.00 |
| Beauty Health (SKIN) | United States | $0.338B | 0.00 |
| LifeMD (LFMD) | United States | $0.329B | 0.00 |
| DocGo (DCGO) | United States | $0.313B | 17.11 |
| Sharecare (SHCR) | United States | $0.310B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.277B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.270B | 0.00 |
| Biodesix (BDSX) | United States | $0.181B | 0.00 |
| So-Young (SY) | China | $0.122B | 41.00 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.049B | 6.66 |
| Oncology Institute (TOI) | United States | $0.047B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| Nutex Health (NUTX) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.029B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.028B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.017B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |